These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Myleran use in leukaemias]. LARRAIN C; MEZA ARRAU C; GERBER K; ZUNIGA C Rev Med Chil; 1957 Sep; 85(9):534-44. PubMed ID: 13518819 [No Abstract] [Full Text] [Related]
23. [Treatment of chronic myeloid leukemia by means of a new chemical antiblastic agent, 1-4-dimethylsulfonoxy-butane]. ESTEVEZ RA Prensa Med Argent; 1958 Apr; 45(16):1644-9. PubMed ID: 13601527 [No Abstract] [Full Text] [Related]
24. [Cytostatic prolonged therapy in chronic leukemia]. KLIMA R; BEYREDER J; HERZOG E Wien Med Wochenschr; 1957 May; 107(18-19):368-71. PubMed ID: 13443328 [No Abstract] [Full Text] [Related]
26. [Result of myleran therapy of leukemias in children]. MUKHAMEDZIANOVA GS Pediatriia; 1958 Aug; 22(8):72-5. PubMed ID: 13590890 [No Abstract] [Full Text] [Related]
27. [Two cases of myeloid splenomegaly with hemorrhagiparous thrombocythemia; effects of myleran, importance of thromboelastograms]. MARCHAL G; DUHAMEL G; LEROUX M; CHENDEROVITCH J; GOGLIN G Sang; 1957; 28(3):245-59. PubMed ID: 13477901 [No Abstract] [Full Text] [Related]
28. Case report chronic myelogenous leukemia; an eight year experience. CASFORD RS Mo Med; 1957 Apr; 54(4):343. PubMed ID: 13418606 [No Abstract] [Full Text] [Related]
29. Treatment of chronic myeloleukosis with myelosan. PAVLOVSKAIA NI Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705 [No Abstract] [Full Text] [Related]
30. Method of treatment of chronic myeloleukosis with myelosan. MOKEEVA RA Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706 [No Abstract] [Full Text] [Related]
31. [1-4-Dimethanesulfoxybutane therapy of chronic leukemic myeloses]. PETRESCU M; PAPAZIAN R; OLARU C Med Interna (Bucur); 1957 May; 9(5):699-709. PubMed ID: 13482655 [No Abstract] [Full Text] [Related]
32. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis]. CHERNOV VA Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704 [No Abstract] [Full Text] [Related]
33. The use of myleran and similar agents in chronic leukemias. GALTON DA Adv Cancer Res; 1956; 4():73-112. PubMed ID: 13381607 [No Abstract] [Full Text] [Related]
34. Myelogenous leukemia: current practice. Ogada T East Afr Med J; 1980 Jan; 57(1):5-6. PubMed ID: 6929249 [No Abstract] [Full Text] [Related]
35. [Mode of action of benemid on renal mechanism of excretion of uric acid]. LEVY M; SAPIR M; STROUN J J Urol Medicale Chir; 1954; 60(5):378-82. PubMed ID: 13202201 [No Abstract] [Full Text] [Related]
36. Myleran in the treatment of lymphomas. SYKES MP Ann N Y Acad Sci; 1958 Apr; 68(3):1035-7. PubMed ID: 13627752 [No Abstract] [Full Text] [Related]
37. Urinary excretion of nucleic acid derivatives in persons with myeloid leukemia. HORRIGAN DL J Clin Invest; 1954 Jun; 33(6):901-6. PubMed ID: 13163183 [No Abstract] [Full Text] [Related]
38. Myleran: a review of its action and a report on its use in chronic myeloid leuchaemia. KURRLE GR Med J Aust; 1955 Apr; 42(1 18):636-41. PubMed ID: 14382871 [No Abstract] [Full Text] [Related]
39. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia. Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615 [No Abstract] [Full Text] [Related]
40. Some aspects of the mechanism of action of derivatives of myleran and nitrogen mustard. TALBOT TR Trans Am Clin Climatol Assoc; 1957-1958; 69():113-7. PubMed ID: 13581093 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]